
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11115260
[patent_doc_number] => 20160312232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'BIOLOGICAL INDICATOR'
[patent_app_type] => utility
[patent_app_number] => 15/204079
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13393
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15204079
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/204079 | Biological indicator | Jul 6, 2016 | Issued |
Array
(
[id] => 14422563
[patent_doc_number] => 10316071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Fusion molecules
[patent_app_type] => utility
[patent_app_number] => 15/203613
[patent_app_country] => US
[patent_app_date] => 2016-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 56
[patent_no_of_words] => 51947
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15203613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/203613 | Fusion molecules | Jul 5, 2016 | Issued |
Array
(
[id] => 12878539
[patent_doc_number] => 20180184688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Methods of Improving Animal Performance
[patent_app_type] => utility
[patent_app_number] => 15/737763
[patent_app_country] => US
[patent_app_date] => 2016-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737763 | Methods of improving animal performance | Jul 3, 2016 | Issued |
Array
(
[id] => 12038763
[patent_doc_number] => 09816992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Compositions and methods relating to Lyme disease'
[patent_app_type] => utility
[patent_app_number] => 15/200657
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 30
[patent_no_of_words] => 39523
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15200657
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/200657 | Compositions and methods relating to Lyme disease | Jun 30, 2016 | Issued |
Array
(
[id] => 13522067
[patent_doc_number] => 20180312576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => ANTIBODIES TARGETING A MANNAN-BASED O-ANTIGEN OF K. PNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 15/768656
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768656
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768656 | ANTIBODIES TARGETING A MANNAN-BASED O-ANTIGEN OF K. PNEUMONIAE | Jun 29, 2016 | Abandoned |
Array
(
[id] => 12449583
[patent_doc_number] => 09982382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Mitigation of odor in cleaning machines and cleaning processes
[patent_app_type] => utility
[patent_app_number] => 15/195597
[patent_app_country] => US
[patent_app_date] => 2016-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21363
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15195597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/195597 | Mitigation of odor in cleaning machines and cleaning processes | Jun 27, 2016 | Issued |
Array
(
[id] => 13278739
[patent_doc_number] => 10150943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 15/184973
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2934
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15184973
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/184973 | None | Jun 15, 2016 | Issued |
Array
(
[id] => 16353344
[patent_doc_number] => 10793846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Compositions and methods for treating celiac sprue disease
[patent_app_type] => utility
[patent_app_number] => 15/575159
[patent_app_country] => US
[patent_app_date] => 2016-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18313
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575159
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575159 | Compositions and methods for treating celiac sprue disease | Jun 7, 2016 | Issued |
Array
(
[id] => 12165342
[patent_doc_number] => 09884100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Lutzomyia longipalpis polypeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 15/175329
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 28812
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15175329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/175329 | Lutzomyia longipalpis polypeptides and methods of use | Jun 6, 2016 | Issued |
Array
(
[id] => 12105224
[patent_doc_number] => 09861690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'Ehrlichia ewingii proteins, nucleic acids, and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 15/174643
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 27936
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174643 | Ehrlichia ewingii proteins, nucleic acids, and methods of their use | Jun 5, 2016 | Issued |
Array
(
[id] => 11262241
[patent_doc_number] => 09486523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Compositions and methods for treating and preventing Staphylococcus aureus infections'
[patent_app_type] => utility
[patent_app_number] => 15/174068
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 11971
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174068 | Compositions and methods for treating and preventing Staphylococcus aureus infections | Jun 5, 2016 | Issued |
Array
(
[id] => 11067671
[patent_doc_number] => 20160264632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A AND B'
[patent_app_type] => utility
[patent_app_number] => 15/166010
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 47741
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166010
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/166010 | Nucleic acids and proteins from streptococcus groups A and B | May 25, 2016 | Issued |
Array
(
[id] => 11053349
[patent_doc_number] => 20160250311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 15/158387
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11264
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/158387 | DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS | May 17, 2016 | Abandoned |
Array
(
[id] => 11054648
[patent_doc_number] => 20160251610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'MICROBES WITH CONTROLLED ADHESIVE PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 15/158343
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16894
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/158343 | MICROBES WITH CONTROLLED ADHESIVE PROPERTIES | May 17, 2016 | Abandoned |
Array
(
[id] => 13026421
[patent_doc_number] => 10035826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Proteins and nucleic acids from meningitis/sepsis-associated
[patent_app_type] => utility
[patent_app_number] => 15/150204
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 75367
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150204
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/150204 | Proteins and nucleic acids from meningitis/sepsis-associated | May 8, 2016 | Issued |
Array
(
[id] => 12112800
[patent_doc_number] => 09868780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'High affinity antibodies that neutralize Staphylococcus enterotoxin B'
[patent_app_type] => utility
[patent_app_number] => 15/144334
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 63
[patent_no_of_words] => 27020
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144334 | High affinity antibodies that neutralize Staphylococcus enterotoxin B | May 1, 2016 | Issued |
Array
(
[id] => 11513002
[patent_doc_number] => 20170080075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/140879
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 23559
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15140879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/140879 | VACCINE | Apr 27, 2016 | Abandoned |
Array
(
[id] => 11122063
[patent_doc_number] => 20160319037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'CLOSTRIDIUM DIFFICILE ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 15/130749
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16378
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130749
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/130749 | Clostridium difficile antigens | Apr 14, 2016 | Issued |
Array
(
[id] => 11031570
[patent_doc_number] => 20160228526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'LPS VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/098563
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8558
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15098563
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/098563 | LPS VACCINE | Apr 13, 2016 | Abandoned |
Array
(
[id] => 11441984
[patent_doc_number] => 20170043005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'CHLAMYDIA ANTIGENS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/080324
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 34109
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080324 | CHLAMYDIA ANTIGENS AND USES THEREOF | Mar 23, 2016 | Abandoned |